Role of S-adenosyl-L-methionine in the treatment of liver diseases

Journal of Hepatology

Volumn 30, Issue 6, 1999, Pages 1155-1159

  Lieber, Charles S ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHIONINE; METHIONINE ADENOSYLTRANSFERASE; S ADENOSYLMETHIONINE;

ALCOHOL LIVER CIRRHOSIS; AMINO ACID BLOOD LEVEL; BIOSYNTHESIS; DRUG EFFECT; DRUG MECHANISM; EDITORIAL; LIVER DISEASE; PRIORITY JOURNAL; SUPPLEMENTATION;

EID: 0033032034     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(99)80274-8     Document Type: Editorial

References (55)

1. Mato JM, Cámara J, Fernández de Paz J, Caballería L, Coll S, Caballero A, et al. S-Adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial. J Hepatol. 30:1999;1081-1089.
2. Finkelstein JD, Cello FP, Kyle WE. Ethanol-induced changes in methionine metabolism in rat liver. Biochem Biophys Res Commun. 61:1974;475-481.
3. Lieber CS, DeCarli LM. An experimental model of alcohol feeding and liver injury in the baboon. J Med Primatol. 3:1974;153-163.
4. Finkelstein JD, Martin JJ. Methionine metabolism in mammals. Adaptation to methionine excess. J Biol Chem. 261:1986;1582-1587.
5. Hardwick DF, Applegarth DA, Cockcroft DM, Ross PM, Cder RJ. Pathogenesis of methionine-induced toxicity. Metabolism. 19:1970;381-391.
6. Iob V, Coon WW, Slona M. Free amino acids in liver, plasma and muscle of patients with cirrhosis of the liver. J Surg Res. 7:1967;41-43.
7. Iber FL, Rosen H, Stanley MA, Levenson SM, Chalmers TC. The plasma amino acids in patients with liver failure. J Lab Clin Med. 50:1957;417-425.
8. Fischer JE, Yoshimura N, Aguirre A, James JH, Cummings MG, Abel RM, et al. Plasma amino acids in patients with hepatic encephalopathy. Effects of amino acids infusions. Am J Surg. 127:1974;40-47.
9. Montanari A, Simoni I, Vallisa D, Trifiro A, Colla R, Abbiati R, et al. Free amino acids in plasma and skeletal muscle of patients with liver cirrhosis. Hepatology. 8:1988;1034-1039.
10. Kinsell LW, Harper HA, Barton HC, Michaels GD, Weiss HA. Rate of disappearance from plasma of intravenously administered methionine in patients with liver damage. Science. 106:1947;589-594.
11. Horowitz JH, Rypins EB, Henderson JM, Heymsfield SB, Moffitt SD, Bain RP, et al. Evidence for impairment of transsulfuration pathway in cirrhosis. Gastroenterology. 81:1981;668-675.
12. Duce AM, Ortiz P, Cabrero C, Mato JM. S-adenosyl-L-methionine synthetase and phospholipid methyltransferase are inhibited in human cirrhosis. Hepatology. 8:1988;65-68.
13. Lieber CS, Casini A, DeCarli LM, Kim C, Lowe N, Sasaki R, et al. S-adenosyl-L-methionine attenuates alcohol-induced liver injury in the baboon. Hepatology. 11:1990;165-172.
14. Lieber CS. Effect of S-Adenosyl-L-Methionine (SAMe) and other natural compounds in alcoholic and nonalcoholic liver injury. Prog Hepato-Pharmacol. 11:1997;81-92.
15. Lieber CS. Metabolism of alcohol. McCullough A, . Clinics in Liver Disease. 1998;673-702 WB Saunders, Philadelphia PA.
16. Speisky H, MacDonald A, Giles G, Orrego H, Israel Y. Increased loss and decreased synthesis of hepatic glutathione after acute ethanol administration. Biochem J. 225:1985;565.
17. Shaw S, Lieber CS. Plasma amino acid abnormalities in the alcoholic: respective role of alcohol, nutrition and liver injury. Gastroenterology. 74:1978;677-682.
18. Cantoni GL. The nature of the active methyl donor formed enzymically from L-methionine and adenosine triphosphate. J Am Chem Soc. 74:1952;2942-2943.
19. Mato JM, Lieber CS, Kaplowitz N, Caballero A. Methionine Metabolism: Molecular Mechanism and Clinical Implications. 1992;1-232 SA Bouncopy, Madrid.
20. Hirata F, Viveros OH, Diliberto EJ Jr., Alexrod J. Identification and properties of two methyltransferases in conversion of phosphatidylethanolamine to phosphatidylcholine. Proc Natl Acad Sci USA. 75:1978;1718-1721.
21. Hirata F, Axelrod J. Phospholipid methylation and biological signal transmission. Science. 209:1980;1082-1090.
22. Yamada S, Mak KM, Lieber CS. Chronic ethanol consumption alters rat liver plasma membranes and potentiates release of alkaline phosphatase. Gastroenterology. 88:1985;1799-1806.
23. Stramentinoli G, Gualano M, Galli-Kienle G. Intestinal absorption of S-adenosyl-L-methionine. J Pharmacol Exp Ther. 209:1979;323-326.
24. Bornbardieri G, Pappalardo G, Bernardi L, Barra D, Di Palma A, Castrini G. Intestinal absorption of S-adenosyl-L-methionine in humans. Int J Clin Pharmacol Ther. 21:1983;186-188.
25. Hoffinan DR, Marion DW, Cornatzer WE, Duerra JA. S-adenosylmethionine and S-adenosylhomocysteine metabolism in isolated rat liver. J Biol Chem. 255:1980;10822-10827.
26. Travers J, Varela I, Mato JM. Effect of exogenous S-adenosyl-L-methionine on phosphatidylcholine synthesis by isolated rat hepatocytes. Biochem Pharmacol. 33:1984;1562-1564.
27. Pezzoli C, Stramentinoli G, Galli-Kienele M, Plaff E. Uptake and metabolism of S-adenosyl-L-methionine by isolated rat hepatocytes. Biochem Biophys Res Commun. 85:1978;1031-1038.
28. Engstrom MA, Benevenga NJ. Rates of oxidation of the methionine and S-adenosylmethionine methyl carbons in isolated rat hepatocytes. J Nutr. 117:1987;1820-1826.
29. Zappia V, Galletti P, Porcelli M. Uptake of adenosylmethionine and related sulfur compounds by isolated rat liver. FEBS Lett. 90:1978;331-335.
30. Quiram DR, Winshilboum RM. Catchol-O-methyltransferase in rat erythrocyte and three other tissues: comparison of biochemical properties after removal of inhibitory calcium. J Neurochem. 27:1976;1197-1203.
31. Audubert F, Vance D. Pitfalls and problems in studies on the methylation of phosphatidylethanolamine. J Biol Chem. 258:1983;10695-10701.
32. Giulidori P, Stramentinoli G. A radioenzymatic method for Sadenosyl-L-methionine determination in biological fluids. Anal Biochem. 137:1984;217-220.
33. Lieber CS, Robins SJ, Li J, DeCarli L, Mak KM, Fasulo JM, et al. Phosphatidylcholine protects against fibrosis and cirrhosis in the baboon. Gastroenterology. 106:1994;152-159.
34. Lieber CS, Robins SJ, Leo MA. Hepatic phosphatidylethanolamine methyltransferase activity is decreased by ethanol and increased by phosphatidylcholine. Alcohol Clin Exp Res. 18:1994;592-595.
35. Feo F, Pascale R, Garcea R, Daino L, Piris L, Frassetto S, et al. Effect of variations of S-adenosyl-L-methionine liver content on fat accumulation and ethanol metabolism in ethanol-intoxicated rats. Toxicol Appl Pharmacol. 83:1986;331-341.
36. Paredes SR, Kozicki PA, Fukuda H, Rossetti MV, Batille AMDC. S-adenosyl-L-methionine: its effect on aminolevulinate dehydratase and glutathione in acute ethanol intoxication. Alcohol. 4:1987;81-85.
37. Gasso M, Rubio M, Varela G, Cabre M, Caballeria J, Alonso E, et al. Effects of S-adenosylmethionine on lipid peroxidation and liver fibrogenesis in carbon tetrachloride-induced cirrhosis. J Hepatol. 25:1996;200-205.
38. Corrales F, Giménez A, Alverez L, Caballeria J, Pajares MA, Andreu H, et al. S-adenosylmethionine treatment prevents carbon tetrachloride-induced S-adenosylmethionine synthetase inactivation and attenuates liver injury. Hepatology. 16:1992;1022-1027.
39. Cabrero C, Duce AM, Ortiz P, Alemany S, Mato JM. Specific loss of the high-molecular-weight form of S-adenosyl-L-methionine synthetase in human liver cirrhosis. Hepatology. 8:1988;1530-1534.
40. Muriel P, Suarez OR, Gonzalez P, Zuńiga L. Protective effect of S-adenosyl-L-methionine on liver damage induced by biliary obstruction in rats: a histological, ultrastructural and biochemical approach. J Hepatol. 21:1994;95-102.
41. Belli DC, Fournier LA, Lepage G, Yousef I, Roy CC. S-adenosyl-L-methionine prevents total parenteral nutrition-induced cholestasis in the rat. J Hepatol. 21:1994;18-23.
42. Giudici GA, Le Grazie C, Di Padova C. The use of ademethionine (SAMe) in the treatment of cholestatic liver disorders: metaanalysis of clinical trials. Mato JM, Lieber C, Kaplowitz N, Caballero A, . Methionine Metabolism: Molecular Mechanism and Clinical Implications. 1992;67-79 CSIC Press, Madrid.
43. Frezza M, Surrenti C, Manzillo G, Fiaccadori F, Bortolini M, Di Padova C. Oral S-adenosylmethionine in the symptomatic treatment of intrahepatic cholestasis: a double-blind placebo controlled study. Gastroenterology. 99:1990;211-215.
44. Frezza M, Pozzato G, Chiesa L, Stramentinoli G, Di Padova C. Reversal of intrahepatic cholestasis of pregnancy in women after high dose S-adenosyl-L-methionine administration. Hepatology. 4:1984;274-278.
45. Angelico M, Gandin C, Nistri A, Baiocchi L, Capocaccia L. Oral S-adenosyl-L-methionine (SAMe) administration enhances bile salt conjugation with taurine in patients with liver cirrhosis. Scand J Clin Invest. 54:1994;459-464.
46. Loguercio C, Nardi G, Argenzio F, Aurilio C, Petrone E, Grella A, et al. Effect of S-adenosyl-L-methionine administration on red blood cell cysteine and glutathione levels in alcoholic patients with and without liver disease. Alcohol Alcohol. 29:1994;597-604.
47. Marchesini G, Bugianesi E, Bianchi G, Fabbri A, Marchi E, Zoli M, et al. Effect of S-adenosyl-L- methionine administration on plasma levels of sulphur-containing amino acids in patients with liver cirrhosis. Clin Nutr. 11:1992;303-308.
48. Vendemiale G, Altomare E, Trizio T, Le Grazie C, Di Padova C, Salerno MT, et al. Effect of oral S-adenosyl-L-methionine on hepatic glutathione in patients with liver disease. Scand J Gastroenterol. 24:1989;407-415.
49. 5-methyltetrahydrofolate-homocysteine methyltransferase in the rat. IRCS Med Sci. 13:1985;760-761.
50. Barak AJ, Beckenhauer HC, Tuma DJ, Donohue TM Jr. Adaptive increase in betaine- homocysteine methyltransferase activity maintains hepatic S-adenosylmethionine levels in ethanol-treated rats. IRCS Med Sci Biochem. 12:1984;866-867.
51. Hoffbauer FW, Zaki FG. Choline deficiency in baboon and rat compared. Arch Pathol. 79:1965;364-369.
52. Hultberg B, Berglund M, Andersson A, Frank A. Elevated plasma homocysteine in alcoholics. Alcohol Clin Exp Res. 17:1993;687-689.
53. Stampfer MJ, Malinow MR, Willett WC, Newcomer LM, Upson B, Ullmann D, et al. A prospective study of plasma homocysteine and risk of myocardial infarction in US physicians. JAMA. 268:1992;877-881.
54. Chedid A, Mendenhall CL, Gartside P, French SW, Chen T, Rabin L, the VA Cooperative Study Group . Prognostic factors in alcoholic liver disease. Am J Gastroenterol. 86:1991;210-216.
55. Adams WL, Yuan Z, Barboriak JJ, Rimm AA. Alcohol-related hospitalizations of elderly people. JAMA. 10:1993;1222-1225.